Literature DB >> 666302

Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.

H C Neu, K P Fu.   

Abstract

Synergistic activity between both azlocillin and mezlocillin and aminoglycosides or cefazolin could be demonstrated by checkerboard dilution, isobologram, and killing curve techniques. Azlocillin and mezlocillin combined with gentamicin, netilmicin, or amikacin were synergistic against Escherichia coli, Klebsiella, Citrobacter, Enterobacter, Serratia, and indole-positive Proteus. Synergy was observed with isolates that were susceptible or resistant to azlocillin or mezlocillin. Synergy was seen most often when azlocillin or mezlocillin were combined with amikacin, gentamicin, or netilmicin against Pseudomonas aeruginosa. The combination of mezlocillin and an aminoglycoside produced synergy more often than did carbenicillin plus an aminoglycoside. No antagonism was seen when aminoglycoside antibiotics were combined with azlocillin or mezlocillin. Cefazolin was synergistic against Pseudomonas, Providencia, P. mirabilis, indole-positive Proteus, Citrobacter, Klebsiella, and Escherichia coli, when combined with azlocillin or mezlocillin. However, the combination of either agent with cefazolin was antagonistic when tested against selected indole-positive Proteus and Enterobacter isolates.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666302      PMCID: PMC352336          DOI: 10.1128/AAC.13.5.813

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  The nephrotoxicity of antimicrobial agents (second of three parts).

Authors:  G B Appel; H C Neu
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

Review 2.  The nephrotoxicity of antimicrobial agents (third of three parts).

Authors:  G B Appel; H C Neu
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

3.  Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle.

Authors:  D Greenwood; F O'Grady
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

4.  The formation of functional penicillin-binding proteins.

Authors:  T E Hamilton; P J Lawrence
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

Review 5.  The nephrotoxicity of antimicrobial agents (first of three parts).

Authors:  G B Appel; H C Neu
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

6.  Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

Authors:  S Schimpff; W Satterlee; V M Young; A Serpick
Journal:  N Engl J Med       Date:  1971-05-13       Impact factor: 91.245

7.  Ticarcillin for treatment of serious infections with gram-negative bacteria.

Authors:  M G Parry; H C Neu
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

8.  In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.

Authors:  J C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  Antibacterial activity of combinations of cefazolin and semisynthetic penicillins.

Authors:  T Okubo; M Inoue; S Mitsuhashi
Journal:  J Antibiot (Tokyo)       Date:  1975-10       Impact factor: 2.649

  10 in total
  21 in total

Review 1.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.

Authors:  R B Clark; C B Pakiz; M K Hostetter
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

3.  Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.

Authors:  K Machka; R Dietz
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

4.  [Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].

Authors:  P M Shah; K Siegel; W Stille
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Combinations of beta lactam antibiotics.

Authors:  S J Pedler; A J Bint
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

6.  In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.

Authors:  J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

7.  Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

9.  Antibacterial activity and beta-lactamase stability of temocillin.

Authors:  K Jules; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

10.  Mezlocillin for treatment of infections in cancer patients.

Authors:  B F Issell; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.